title: Exploitation of adaptive evolution in glioma treatment.
abstract: Glioblastoma multiforme (GBM) is a malignant neoplasm of the CNS with almost uniform lethality. Even with standard-of-care treatments, the prognosis for patients remains dismal. GBM, as with other malignancies, often acquires treatment resistance after an initial response to therapy. Treatment resistance may come about through the adaptive evolution of tumors in response to selection pressures from treatment interventions and the microenvironment. This review discusses how adaptive evolution might potentially be exploited as a new paradigm in GBM treatment.
authors: Ryan
authors: R
authors: Cordner
authors: Keith L
authors: KL
authors: Black
authors: Christopher J
authors: CJ
authors: Wheeler
mesh_terms: D005075:Biological Evolution; D016543:Central Nervous System Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D004358:Drug Therapy; D005909:Glioblastoma / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*
references: Oncogene. 2009 Apr 16;28(15):1807-11
references: 19287454
references: Cancer Res. 2004 Oct 15;64(20):7629-33
references: 15492292
references: Neoplasia. 2012 Feb;14(2):150-8
references: 22431923
references: Cancer Cell. 2007 Jan;11(1):69-82
references: 17222791
references: Cancer Res. 2001 Sep 15;61(18):6713-5
references: 11559541
references: Cell. 2011 Jan 7;144(1):27-40
references: 21215367
references: Cell. 2012 Mar 2;148(5):886-95
references: 22385958
references: Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4274-80
references: 21262804
references: J Natl Cancer Inst. 1993 May 5;85(9):704-10
references: 8478956
references: J Neurosurg. 2000 Jun;92(6):983-90
references: 10839259
references: Clin Cancer Res. 2009 Aug 15;15(16):5145-53
references: 19671863
references: Cancer Res. 2009 Jun 1;69(11):4894-903
references: 19487300
references: Cancer Res. 2004 Jul 15;64(14):4973-9
references: 15256471
references: Nat Immunol. 2002 Nov;3(11):991-8
references: 12407406
references: PLoS One. 2012;7(4):e35262
references: 22536362
references: Expert Rev Vaccines. 2011 Jun;10(6):875-86
references: 21692706
references: Cancer Res. 2004 Sep 15;64(18):6503-10
references: 15374961
references: Cancer Cell. 2010 Jan 19;17(1):98-110
references: 20129251
references: Cancer Cell. 2010 May 18;17(5):510-22
references: 20399149
references: Cell. 2012 May 25;149(5):979-93
references: 22608084
references: N Engl J Med. 2001 Jan 11;344(2):114-23
references: 11150363
references: Cancer Res. 2003 Sep 15;63(18):5821-8
references: 14522905
references: J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9
references: 9776413
references: Oncogene. 2003 Jul 31;22(31):4918-23
references: 12894235
references: Cancer Res. 2006 Jan 1;66(1):159-67
references: 16397228
references: Cancer Res. 2009 Oct 1;69(19):7499-502
references: 19752088
references: Nature. 1992 Feb 27;355(6363):846-7
references: 1311419
references: Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):825-30
references: 11020580
references: Cancer Res. 2012 Apr 1;72(7):1614-20
references: 22311673
references: Bull Cancer. 2005 Apr;92(4):301-9
references: 15888386
references: Neurosurgery. 1999 Dec;45(6):1279-91; discussion 191
references: 10598694
references: Nature. 2010 Dec 9;468(7325):829-33
references: 21102433
references: J Natl Cancer Inst. 2007 Oct 17;99(20):1544-50
references: 17925535
references: Nature. 2010 Dec 9;468(7325):824-8
references: 21102434
references: Oncogene. 1999 Jul 15;18(28):4144-52
references: 10435596
references: Science. 1976 Oct 1;194(4260):23-8
references: 959840
references: J Oncol. 2012;2012:376894
references: 22685459
references: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references: 20610543
references: Blood. 2012 Aug 2;120(5):1067-76
references: 22498740
references: Nature. 2012 Feb 15;483(7390):479-83
references: 22343889
references: Nat Med. 2011 Mar;17(3):320-9
references: 21383745
references: PLoS Comput Biol. 2007 Dec;3(12):e250
references: 18085819
references: Neuro Oncol. 2001 Jul;3(3):152-8
references: 11465395
references: Cell Cycle. 2010 Aug 1;9(15):3012-21
references: 20714216
references: Cancer Res. 2001 Feb 1;61(3):842-7
references: 11221866
references: PLoS One. 2010 Jun 07;5(6):e10974
references: 20539758
references: Cancer Cell. 2006 Mar;9(3):157-73
references: 16530701
references: J Natl Cancer Inst. 2012 Aug 22;104(16):1251-9
references: 22855780
references: PLoS One. 2010 Sep 03;5(9):e12548
references: 20838435
references: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50
references: 20876136
references: Clin Cancer Res. 2004 Aug 15;10(16):5316-26
references: 15328167
references: J Natl Cancer Inst. 2011 Nov 2;103(21):1588-95
references: 22010181
references: Cell. 2012 May 25;149(5):994-1007
references: 22608083
references: Cancer Res. 1992 Feb 1;52(3):674-9
references: 1346255
references: Nature. 2012 Feb 15;483(7390):474-8
references: 22343901